Literature DB >> 8930942

Incidence and risk factors of ischaemic and haemorrhagic stroke in Europe. EUROSTROKE: A collaborative study among research centres in Europe: rationale and design.

D E Grobbee1, P J Koudstaal, M L Bots, L A Amaducci, P C Elwood, J Ferro, A Freire de Concalves, O Krüger, D Inzitari, Y Nikitin, J T Salonen, J Sivenius, W Scheuermann, D S Thelle, A Trichopoulou, J T Tuomilehto.   

Abstract

EUROSTROKE is a collaborative study among ten European research centres to investigate (1) the variation in incidence of fatal and non-fatal ischaemic and haemorrhagic stroke among populations in different European countries; (2) whether the observed differences in stroke incidence across countries can be explained by differences in prevalence of established cardiovascular risk factors; (3) the relative importance of selected dietary factors (potassium intake, smoking, alcohol consumption), haemostatic disturbances (fibrinogen) and co-morbidity (rheumatic heart disease, atrial fibrillation) compared to established risk factors as determinants of the occurrence of ischaemic and haemorrhagic stroke. The EUROSTROKE database is drawn from ten European population-based prospective follow-up studies (cohorts) and is designed as a case-control study nested within these ten ongoing studies.

Entities:  

Mesh:

Year:  1996        PMID: 8930942     DOI: 10.1159/000109919

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

1.  The EUROSTROKE cohorts: a short description and data analytical approach.

Authors:  M L Bots; P C Elwood; Y Nikitin; J T Salonen; A Freire de Concalves; D Inzitari; J Sivenius; A Trichopoulou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

2.  Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?

Authors:  K G M Moons; M L Bots; J T Salonen; P C Elwood; A Freire de Concalves; Y Nikitin; J Sivenius; D Inzitari; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

3.  Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project.

Authors:  M L Bots; J T Salonen; P C Elwood; Y Nikitin; A Freire de Concalves; D Inzitari; J Sivenius; A Trichopoulou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

4.  Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; P C Elwood; J T Salonen; A Freire de Concalves; J Sivenius; A Di Carlo; Y Nikitin; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

5.  Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; Y Nikitin; J T Salonen; P C Elwood; S Malyutina; A Freire de Concalves; J Sivenius; A Di Carlo; P Lagiou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

6.  What is the association of lipid levels and incident stroke?

Authors:  Stephen P Glasser; Aleena Mosher; George Howard; Maciej Banach
Journal:  Int J Cardiol       Date:  2016-06-23       Impact factor: 4.164

7.  Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; P C Elwood; Y Nikitin; J T Salonen; A Freire de Concalves; D Inzitari; J Sivenius; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

8.  Age- and sex-related difference of lipid profile in patients with ischemic stroke in China.

Authors:  Pingsen Zhao; Sudong Liu; Zhixiong Zhong; Jing Liu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.